期刊文献+

冷冻干燥对重组酵母乙型肝炎疫苗效力(抗原性)的影响 被引量:5

The effect of freeze-drying on the potency of recombinant yeast hepatitis B vaccine
下载PDF
导出
摘要 重组酵母乙型肝炎疫苗 (酵母乙肝疫苗 )加入保护剂后冷冻干燥 ,观察是否影响疫苗抗原性和稳定性。按 5 %和 1%的比例 ,在酵母乙肝疫苗原液中分别加入蔗糖和明胶 ,低温冷冻干燥 ,制备 3批冻干疫苗 ,分别进行体外相对效力和小鼠ED50 测定。加保护剂冻干后酵母乙肝疫苗体外相对效力和小鼠ED50 值较冻干前改变不大 ,而 4℃放置和热加速后的稳定性均优于液体疫苗。因此现有酵母乙肝疫苗加入保护剂冻干后 ,显著提高了疫苗的稳定性 ,为进一步制备稳定的疫苗参考品打下了初步基础。 Three bulks of freeze dried recombinant hepatitis B vaccines were prepared by adding 5% saccharose and 1% gelatine as stabilizer.There were no significant differences both in relative potency in vitro and mouse ED 50 between freeze dried vaccine and liquid one.The stability of freeze dried vaccine was superior to that of liquid one,at 4℃ storage and after heating acceleration test.The results provided basis to preparation stable reference in freeze dried form for the vaccine production.
出处 《微生物学免疫学进展》 2003年第2期16-18,共3页 Progress In Microbiology and Immunology
关键词 乙肝疫苗 稳定性 参考品 冷冻 Hepatitis B Vaccine Stability Referencel Freeze drying
  • 相关文献

参考文献5

二级参考文献8

  • 1Stephenne J. Development and production aspect of a recombinant yeast - derived hepatitis B vaccine. Vaccine, 1990, 8 ( Supll ) : S69 -S73. 被引量:1
  • 2Andre FE, Safary A. Summary of clinical findings on Engerix - B, a genetically engineered yeast - derived hepatitis B vaccine. Postgrad Med J, 1987, 63 (Suppl.2) :169. 被引量:1
  • 3Andre FE, Zuckerman AJ. Reviews: Protective efficacy of hepatitis vaccines in Neonates. J Med Virol, 1994, 44:144- 151. 被引量:1
  • 4Bitter GA, Egan KM, Bumette WN, et al. Hepatitis B vaccine produced in yeast. J Medd Virod, 1988, 25:123- 140. 被引量:1
  • 5Diminsky D, Schimbeck, Reimann J, et al. Comparison between hepatitis B surface antigen (HBsAg) particles derived from mammalian cells (CHO) and yeast cells (Hansenula polymorpha): composition, structure and immumogenicity. Vaccine, 1997, 15 (6/7) :637-647. 被引量:1
  • 6孙耀东,王珑.设施与环境因素对实验动物的影响[J]实验动物科学与管理,1995(02). 被引量:1
  • 7王秀清,郑方治,娄蒙男,邹岩柏.清洁级实验动物实验设施的改建和应用[J]实验动物科学与管理,1995(02). 被引量:1
  • 8刘崇柏,徐志一,曹惠霖,孙永德,荆庆,陈大保,陈美征,谢永富.急性病毒性肝炎的发病率慢性肝炎患病率和肝病死亡率的研究[J].病毒学报,1991,7(A12):1-7. 被引量:49

共引文献8

同被引文献28

  • 1金立杰,赵小琳,方艳秋,杨丽华,王志.乙型肝炎疫苗-卡介苗联合疫苗细胞免疫的研究[J].中国生物制品学杂志,2006,19(2):171-173. 被引量:5
  • 2赵小琳,刘延明,陈万革,金立杰.乙型肝炎卡介苗联合疫苗稳定性的研究[J].微生物学杂志,2007,27(2):41-44. 被引量:2
  • 3刘崇柏.全国乙型肝炎表面抗原亚型分布[J].中华微生物学和免疫学杂志,1986,:58-58. 被引量:2
  • 4李雪翔 史久华 等.重组乙型肝炎疫苗肌肉和皮内接种的抗体应答率比较[J].国外医学(预防、诊断、治疗用生物制品分册),1993,16(6):263-263. 被引量:2
  • 5Descamps J, Mary A, Rommel E, et al. Release potency tests of hepatitis vaccines. Dev Biol Stand, 1999, 101: 259-294. 被引量:1
  • 6World Health Organization. Requirement for hepatitis B vaeeines made by recombinant DNA techniques (Requirements for Biological Substances No 45, amendment 1997). WHO Technical Report Series, 1999, 889: 94-95. 被引量:1
  • 7Giffroy D, Mazy C, Duchene M. Validation of a new ELISA method for in vitro potency assay of hepatitis B-containing vaccines. Pharmeuropa Bio, 2006, 2006 ( 1 ): 7-14. 被引量:1
  • 8Cuervo ML, Sterling AL, Nicot IA, et ah Validation of a new alternative for determining in vitro potency in vaccines containing hepatitis B from two different manufacturers. Biologicals, 2008, 36 (6): 375-382. 被引量:1
  • 9Vranckx RP. Potency tests for hepatitis B virus vaccines in laboratory animals. Dev Biol Stand, 1983, 54: 63-70. 被引量:1
  • 10World Health Organization. Requirement for hepatitis B vaccines made by recombinant DNA techniques. WHO Technical Report Series, 1989, 786: 38-60. 被引量:1

引证文献5

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部